These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23259835)

  • 21. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studying Dynamic Myofiber Aggregate Reorientation in Dilated Cardiomyopathy Using In Vivo Magnetic Resonance Diffusion Tensor Imaging.
    von Deuster C; Sammut E; Asner L; Nordsletten D; Lamata P; Stoeck CT; Kozerke S; Razavi R
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):e005018. PubMed ID: 27729361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional heterogeneity of function in hypertrophic cardiomyopathy.
    Kramer CM; Reichek N; Ferrari VA; Theobald T; Dawson J; Axel L
    Circulation; 1994 Jul; 90(1):186-94. PubMed ID: 8025995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
    Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
    Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular systolic function changes in hypertrophic cardiomyopathy patients detected by the strain of different myocardium layers and longitudinal rotation.
    Huang J; Yan ZN; Fan L; Rui YF; Song XT
    BMC Cardiovasc Disord; 2017 Aug; 17(1):214. PubMed ID: 28768478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular wall thickness and regional systolic function in patients with hypertrophic cardiomyopathy. A three-dimensional tagged magnetic resonance imaging study.
    Dong SJ; MacGregor JH; Crawley AP; McVeigh E; Belenkie I; Smith ER; Tyberg JV; Beyar R
    Circulation; 1994 Sep; 90(3):1200-9. PubMed ID: 8087929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of noninvasively measured left ventricular mechanics with in vitro muscle contractile performance: a prospective study in hypertrophic cardiomyopathy patients.
    Dhillon A; Sweet W; Popovic ZB; Smedira NG; Thamilarasan M; Lytle BW; Tan C; Starling RC; Lever HM; Moravec CS; Desai MY
    J Am Heart Assoc; 2014 Nov; 3(6):e001269. PubMed ID: 25389286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micro-computed tomography (micro-CT) for the assessment of myocardial disarray, fibrosis and ventricular mass in a feline model of hypertrophic cardiomyopathy.
    Novo Matos J; Garcia-Canadilla P; Simcock IC; Hutchinson JC; Dobromylskyj M; Guy A; Arthurs OJ; Cook AC; Luis Fuentes V
    Sci Rep; 2020 Nov; 10(1):20169. PubMed ID: 33214588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Moon JC; Reed E; Sheppard MN; Elkington AG; Ho SY; Burke M; Petrou M; Pennell DJ
    J Am Coll Cardiol; 2004 Jun; 43(12):2260-4. PubMed ID: 15193690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart.
    Cardim N; Oliveira AG; Longo S; Ferreira T; Pereira A; Reis RP; Correia JM
    J Am Soc Echocardiogr; 2003 Mar; 16(3):223-32. PubMed ID: 12618730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-mortem cardiac diffusion tensor imaging: detection of myocardial infarction and remodeling of myofiber architecture.
    Winklhofer S; Stoeck CT; Berger N; Thali M; Manka R; Kozerke S; Alkadhi H; Stolzmann P
    Eur Radiol; 2014 Nov; 24(11):2810-8. PubMed ID: 25052077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Submillimeter diffusion tensor imaging and late gadolinium enhancement cardiovascular magnetic resonance of chronic myocardial infarction.
    Pashakhanloo F; Herzka DA; Mori S; Zviman M; Halperin H; Gai N; Bluemke DA; Trayanova NA; McVeigh ER
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):9. PubMed ID: 28122618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
    Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.